Optimizing iontophoretic drug delivery: identification and distribution of the charge-carrying species.
OBJECTIVE
To identify and quantify, in vitro and in vivo (in humans), the charge-carrying species during transdermal iontophoresis of lidocaine hydrochloride as a function of the concentration of drug relative to that of sodium chloride in the anodal solution.


METHODS
In vitro experiments in standard diffusion cells quantified lidocaine delivery and the outward migration of chloride across the skin. Electrotransport of Na+ was inferred by difference, allowing transport numbers of the three main charge-carrying species to be deduced. In vivo, outward electrotransport of Cl- was measured and compared to the corresponding in vitro results.


RESULTS
The transport number of lidocaine increased linearly with increasing mole fraction and reached 0.15-0.20 at X(L) = 1.0. In the absence of Na+, most of the charge was carried by Cl- (>80%) despite the skin retaining its net negative charge and cation permselectivity. In vivo data correlated very well with in vitro results.


CONCLUSIONS
The mole faction of drug (relative to competing ions of like polarity) is the crucial determinant of the extent to which it can carry charge across the skin during iontophoresis. The outward electromigration of Cl-, in the sense opposite to drug delivery, may offer a useful means by which to optimize iontophoretic efficiency in the absence of competing cations in the anode formulation.
Marro
D
D
Centre interuniversitaire de recherche et d'enseignement, Universities of Geneva and Lyon Pharmapeptides F-74166 Archamps, France.
Kalia
Y N
YN
Delgado-Charro
M B
MB
Guy
R H
RH
D000279:Administration, Cutaneous; D000818:Animals; D016503:Drug Delivery Systems; D066298:In Vitro Techniques; D007478:Iontophoresis; D008012:Lidocaine / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D008954:Models, Biological; D012867:Skin / Q000378:metabolism*; D013552:Swine
D008012:Lidocaine